Clinical trial
Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
NCT00181636 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181636 |
|---|---|
| Title | Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Galantamine-CR |
| Enrollment | 25 |
| Completion | Oct 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: